TITLE

Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report)

AUTHOR(S)
Tajima, Takeshi; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke
PUB. DATE
June 2013
SOURCE
Journal of Infection & Chemotherapy (Springer Science & Business;Jun2013, Vol. 19 Issue 3, p510
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We previously conducted nationwide surveillance of Streptococcus pneumoniae in 2000-2001 (period 1) and 2004 (period 2) and reported the findings. Subsequent surveillance surveys conducted in 2007 (period 3) and 2010 (period 4) are now reported. Bacterial strains were clinically isolated from children with meningitis, sepsis, and respiratory tract infections at 27 hospitals participating in the Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease. Twenty-one drugs were investigated for 283 isolated strains in period 3, and 24 drugs were investigated for 459 strains in period 4. In period 3, 43.8 % of strains were penicillin-susceptible S. pneumoniae (PSSP), 52.3 % were penicillin-intermediate S. pneumoniae (PISP), and 3.9 % were penicillin-resistant S. pneumoniae (PRSP). In period 4, the percentages were PSSP 23.1 %, PISP 49.9 %, and PRSP 27.0 %. The resistance rates were 56.2 % and 76.9 %, respectively. Drug sensitivity was best with panipenem, at a minimum inhibitory concentration (MIC) ≤0.063 μg/ml in period 3, and with tebipenem (MIC ≤ 0.063 μg/ml) in period 4. Patients' background factors related to increased bacterial resistance were investigated, and significant differences were found depending on whether a child had siblings ( P = 0.0056) or was a daycare center attendee ( P = 0.0195) in period 3, and age category ( P = 0.0256) in period 4. No factors were common to both periods 3 and 4. Pneumococcus is a major causative organism of pediatric infectious disease, and we plan to continue conducting surveillance and providing information in the future.
ACCESSION #
88228636

 

Related Articles

  • The Continuing Challenge of Lower Respiratory Tract Infections. Robert C.3 Moellering Jr. // Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS319 

    The discovery and clinical application of antibiotics has markedly changed the management of a wide variety of respiratory tract infections, including community acquired pneumonia (CAP), during the past half-century. One of the factors that could account for the persistence of problematic...

  • Interpreting Assays for the Detection of Streptococcus pneumoniae. Blaschke, Anne J. // Clinical Infectious Diseases;2011, Vol. 52 Issue suppl_4, pS331 

    Streptococcus pneumoniae is both an aggressive pathogen and a normal part of the human respiratory microbiome. Clinicians and microbiologists have struggled to develop tests that can identify pneumococcal respiratory infection and accurately distinguish colonization from invasive disease....

  • Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance. Hjálmarsdóttir, Martha Á.; Pétursdóttir, Brynhildur; Erlendsdóttir, Helga; Haraldsson, Gunnsteinn; Kristinsson, Karl G. // Journal of Antimicrobial Chemotherapy (JAC);Aug2015, Vol. 70 Issue 8, p2203 

    Objectives The objective of this study was to investigate the prevalence of pilus islets [pilus islet 1 (PI-1) and pilus islet 2 (PI-2)] in pneumococcal isolates from healthy Icelandic preschool children attending day care centres, prior to the introduction of conjugated pneumococcal vaccine,...

  • Quinolone Resistance Mechanisms in Pneumococci. Eliopoulos, George M. // Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS350 

    Quinolones are widely used in the treatment of respiratory infections, in large part because of their activity against Streptococcus pneumoniae and other commonly encountered respiratory tract pathogens. Pneumococcal isolates that are resistant to these "respiratory quinolones" have now begun to...

  • Antimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal. Ndiaye, Aissatou Gueye; Boye, Cheikh Saadbou; Hounkponou, Edwige; Gueye, Fatou Bintou; Badiane, Aida // Journal of Infection in Developing Countries;2009, Vol. 3 Issue 9, p660 

    Background : Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pyogenes, and Streptococcus pneumoniae are the most common causative agents of respiratory tract infections (RTIs). The increase in resistance to current antibacterial agents highlights the need to monitor the resistance...

  • Bacterial and Viral Throat Flora. Hable, Kathleen A.; Washington, John A.; Herrmann Jr., Ernest C. // Clinical Pediatrics;Apr1971, Vol. 10 Issue 4, p199 

    The article presents information on bacterial and viral throat flora. Acute upper respiratory tract infection was defined as illness having a sudden onset with rhinorrhea, pharyngitis, or cough indicating mucosal involvement of the nose, throat, or bronchi. A number of bacteria, including...

  • Telithromycin: A Ketolide Antibiotic for Treatment of Respiratory Tract Infections. Lonks, John R.; Goldmann, Donald A. // Clinical Infectious Diseases;6/1/2005, Vol. 40 Issue 11, p1657 

    Telithromycin, a recently approved ketolide antibiotic derived from 1 4-membered macrolides, is active against erythromycin- resistant pneumococci. Telithromycin has enhanced activity in vitro because it binds not only to domain V of ribosomal RNA (like macrolides do) but also to domain II....

  • Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Jenkins, Stephen G.; Brown, Steven D.; Farrell, David J. // Annals of Clinical Microbiology & Antimicrobials;2008, Vol. 7, Special section p1 

    Background: The increasing prevalence of resistance to established antibiotics among key bacterial respiratory tract pathogens, such as Streptococcus pneumoniae, is a major healthcare problem in the USA. The PROTEKT US study is a longitudinal surveillance study designed to monitor the...

  • Sigara İçiminin Nazofarinks'de Potansiyel Patojenlerin Taşıyıcılığına Etkisi. Yetkin, Gülay; Ay, Selma; Yetkin, Özkan; Taştekin, Neşe; Güçlüer, Nilay // Erciyes Medical Journal / Erciyes Tip Dergisi;2010, Vol. 32 Issue 1, p9 

    Purpose: Smoking is associated with an increased risk of respiratory tract infections in adults and also with oral colonization by some potentially pathogenic microorganisms. Smoking or passive exposure is enhancing bacterial adherence of pathogenic bacteria to the epithelial cells of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics